Drugs / Betneval
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03025282 Comparator | Nov 2016 → Mar 2017 | psoriasis | Galderma R&D | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Betneval | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03025282 ↗ |
| Route | Topical | “Betneval 0.1% ointment” NCT03025282 ↗ |